Pleural Mesothelioma
📧 Sign up to get email alerts when something new happens for Pleural Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 trial results of NUC-3373 in combination with other agents in patients with advanced solid tumors; study status terminated with re…
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Update: MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma [Phase 3]
Phase 3 trial evaluating MEDI5752 in combination with carboplatin and pemetrexed for unresectable pleural mesothelioma is currently active b…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma [Phase 2]
Phase 2 trial evaluating Fianlimab with cemiplimab and chemotherapy, or cemiplimab with chemotherapy, in patients with pleural mesothelioma.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants [Phase 2]
Phase 2 trial comparing nivolumab plus ipilimumab versus pemetrexed with platinum for unresectable pleural mesothelioma in Chinese participa…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers [Phase 2]
Phase II trial of XmAb20717 for advanced rare cancers has been suspended, with eligibility including microsatellite instability-high cancers…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) [Phase 2]
A Phase 2 study evaluating SAR444245 in combination with other anticancer therapies for pleural mesothelioma and non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma [Phase 1]
Phase 1 study of Galinpepimut-S in combination with nivolumab for pleural mesothelioma has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: CAR T Cells in Mesothelin Expressing Cancers [Phase 1]
Phase 1 study evaluating mesothelin-targeted CAR T cells in mesothelin-expressing cancers; results have been posted for a University of Penn…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: eRAPID: Online Symptom Reporting in Lung Cancer [NA]
The eRAPID online symptom reporting study in thoracic cancers has completed, including non-small cell lung cancer, small-cell lung cancer, a…
-
CLINICAL_TRIALS trial_result · 2024-02-29Clinical Trial Update: Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma [Phase 2]
Phase 2 trial update evaluating nivolumab and ipilimumab with or without UV1 vaccination as second-line therapy for malignant mesothelioma.
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: Diadem to Investigate the Activity and Safety of Durvalumab [Phase 2]
Phase 2 trial update investigating durvalumab activity and safety in pleural mesothelioma has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating tumor-infiltrating lymphocytes (TILs) and low-dose IL-2 after cyclophosphamide and fludarabine in pleural mesothe…
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia [Phase 4]
Phase 4 trial comparing regional anesthesia during thoracoscopy to conventional general anesthesia in pleural disease settings; status curre…
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients [Phase 3]
A Phase 3 trial comparing nivolumab plus ipilimumab versus pemetrexed with cisplatin or carboplatin as first-line therapy in unresectable pl…
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma [Phase 2]
Phase II trial update for MEDI4736 (durvalumab) in combination with chemotherapy as first-line treatment for unresectable mesothelioma; stud…
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: Trimodal Lung-Sparing Treatment of Pleural Mesothelioma [Phase 2]
Phase 2 trial update on trimodal, lung-sparing treatment for pleural mesothelioma; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma [Phase 2]
This Phase 2 randomized, double-blind study compares tremelimumab to placebo in unresectable malignant mesothelioma, with results posted in …
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma [Phase 2]
Phase 2 trial evaluating pemetrexed plus cisplatin followed by surgery and radiation for mesothelioma was terminated.
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma [Phase 2]
A Phase 2 trial of tivantinib in previously treated malignant mesothelioma was terminated, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy [Phase 2]
Phase II trial evaluating IMC-A12 in mesothelioma patients who had prior chemotherapy has completed, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer [Phase 1, Phase 2]
A Phase I/II trial of PTK787 with pemetrexed, with or without cisplatin, for non-small cell lung cancer and pleural mesothelioma has been te…